These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2475577)

  • 1. Lack of immunodominance in the T cell response to herpes simplex virus glycoprotein D after administration of infectious virus.
    Yamashita K; Heber-Katz E
    J Exp Med; 1989 Sep; 170(3):997-1002. PubMed ID: 2475577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity.
    BenMohamed L; Bertrand G; McNamara CD; Gras-Masse H; Hammer J; Wechsler SL; Nesburn AB
    J Virol; 2003 Sep; 77(17):9463-73. PubMed ID: 12915561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell responses to synthetic peptides of herpes simplex virus type 1 glycoprotein D in naturally infected individuals.
    Damhof RA; Drijfhout JW; Scheffer AJ; Wilterdink JB; Welling GW; Welling-Wester S
    Arch Virol; 1993; 130(1-2):187-93. PubMed ID: 8503783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Native HSV glycoprotein D subunit vaccine: analysis of in vitro T-cell activation and antigen presentation.
    Ishizaka ST; Mishkin EM
    Viral Immunol; 1991; 4(3):187-93. PubMed ID: 1667262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overlapping T cell antigenic sites on a synthetic peptide fragment from herpes simplex virus glycoprotein D, the degenerate MHC restriction elicited, and functional evidence for antigen-Ia interaction.
    Heber-Katz E; Valentine S; Dietzschold B; Burns-Purzycki C
    J Exp Med; 1988 Feb; 167(2):275-87. PubMed ID: 2450157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
    Bettahi I; Nesburn AB; Yoon S; Zhang X; Mohebbi A; Sue V; Vanderberg A; Wechsler SL; BenMohamed L
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4643-53. PubMed ID: 17898288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional T cell recognition of synthetic peptides corresponding to continuous antibody epitopes of herpes simplex virus type 1 glycoprotein D.
    Wyckoff JH; Osmand AP; Eisenberg RJ; Cohen GH; Rouse BT
    Immunobiology; 1988 May; 177(2):134-48. PubMed ID: 2456985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interplay of T cell responses to viral and autoimmune epitopes.
    Heber-Katz E
    Immunol Res; 1998; 17(1-2):83-7. PubMed ID: 9479570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD.
    Zarling JM; Moran PA; Burke RL; Pachl C; Berman PW; Lasky LA
    J Immunol; 1986 Jun; 136(12):4669-73. PubMed ID: 2423598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferative T-cell response to glycoprotein B of the human herpes viruses: the influence of MHC and sequence of infection on the pattern of cross-reactivity.
    Chan WL; Tizard ML; Faulkner L
    Immunology; 1989 Sep; 68(1):96-101. PubMed ID: 2553584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.
    Khan AA; Srivastava R; Chentoufi AA; Geertsema R; Thai NT; Dasgupta G; Osorio N; Kalantari M; Nesburn AB; Wechsler SL; BenMohamed L
    J Virol; 2015 Jul; 89(13):6619-32. PubMed ID: 25878105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of overlapping class I and class II H-2d-restricted T cell determinants of influenza virus N1 neuraminidase that require infectious virus for presentation.
    Wysocka M; Eisenlohr LC; Otvos L; Horowitz D; Yewdell JW; Bennink JR; Hackett CJ
    Virology; 1994 May; 201(1):86-94. PubMed ID: 7513927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an HSV-1/HSV-2 cross-reactive T cell determinant.
    Grammer SF; Sette A; Colón S; Walker L; Chesnut R
    J Immunol; 1990 Oct; 145(7):2249-53. PubMed ID: 1697879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus glycoprotein D is recognized as antigen by CD4+ and CD8+ T lymphocytes from infected mice. Characterization of T cell clones.
    Johnson RM; Lancki DW; Fitch FW; Spear PG
    J Immunol; 1990 Jul; 145(2):702-10. PubMed ID: 1973187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted delivery of DNA encoding herpes simplex virus type-1 glycoprotein D enhances the cellular response to primary viral challenge.
    Rogers JV; Bigley NJ; Chiou HC; Hull BE
    Arch Dermatol Res; 2000 Nov; 292(11):542-9. PubMed ID: 11194892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of helper T cell antigenic sites in mice from the haemagglutinin glycoprotein of measles virus.
    Obeid OE; Partidos CD; Steward MW
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2549-57. PubMed ID: 7506296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of protective immune responses to the glycoprotein H-glycoprotein L complex of herpes simplex virus type 1.
    Browne H; Baxter V; Minson T
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2813-7. PubMed ID: 8277292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of herpes simplex virus glycoprotein D on antigen presenting cells infected with vaccinia recombinants and protective immunity.
    Wachsman M; Aurelian L; Hunter JC; Perkus ME; Paoletti E
    Biosci Rep; 1988 Aug; 8(4):323-34. PubMed ID: 3263886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential T cell response induced by certain recombinant oligopeptides of herpes simplex virus glycoprotein B in mice.
    Tizard ML; Chan WL
    J Gen Virol; 1997 Jul; 78 ( Pt 7)():1625-32. PubMed ID: 9225039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.